Proair hfa and Lenalidomide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Proair hfa (albuterol sulfate) and Lenalidomide (lenalidomide). Common drug interactions include bone marrow failure among females and constipation among males.

The phase IV clinical study analyzes what interactions people have when they take Proair hfa and Lenalidomide. It is created by eHealthMe based on reports of 63 people who take the same drugs from the FDA, and is updated regularly.

What is Proair hfa?

Proair hfa has active ingredients of albuterol sulfate. It is often used in asthma. eHealthMe is studying from 53,227 Proair hfa users. Check the latest studies of Proair hfa.

What is Lenalidomide?

Lenalidomide has active ingredients of lenalidomide. eHealthMe is studying from 52,881 Lenalidomide users. Check the latest studies of Lenalidomide.



On Jul, 19, 2026

63 people who take Proair hfa and Lenalidomide together, and have interactions are studied.

Proair hfa and Lenalidomide drug interactions.

What are the common drug interactions of Proair Hfa and Lenalidomide, by gender? *:

female:

  1. Bone marrow failure
  2. Bone pain
  3. Bowen's disease (early stage of skin cancer)
  4. Cardiac failure
  5. Cardiac failure congestive
  6. Cellulitis (infection under the skin)
  7. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  8. Chapped lips (cracking, fissuring, and peeling of the skin f lip)
  9. Chest pain
  10. Confusional state

male:

  1. Constipation
  2. Pneumonia
  3. Gait disturbance
  4. Hypercalcaemia (elevated calcium (ca+) level in the blood)
  5. Hyperglycaemia (high blood sugar)
  6. Hypertension (high blood pressure)
  7. Leukopenia (less number of white blood cells in blood)
  8. Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)
  9. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  10. Rash

What are the common drug interactions of Proair Hfa and Lenalidomide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Colonoscopy

40-49:

  1. Bone pain
  2. Headache (pain in head)
  3. Hot flush (sudden feelings of heat)
  4. Pruritus (severe itching of the skin)

50-59:

  1. Fall
  2. Gait disturbance
  3. Hypercalcaemia (elevated calcium (ca+) level in the blood)
  4. Hyperglycaemia (high blood sugar)
  5. Hyperkalaemia (damage to or disease of the kidney)
  6. Hypertension (high blood pressure)
  7. Leukopenia (less number of white blood cells in blood)
  8. Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)
  9. Mobility decreased (ability to move is reduced)
  10. Pain

60+:

  1. Pneumonia
  2. Constipation
  3. Electrolyte imbalance
  4. Fatigue (feeling of tiredness)
  5. Gait disturbance
  6. Hypercalcaemia (elevated calcium (ca+) level in the blood)
  7. Hyperglycaemia (high blood sugar)
  8. Hypertension (high blood pressure)
  9. Leukopenia (less number of white blood cells in blood)
  10. Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)

What are the existing conditions these people have? *

  1. Multiple Myeloma (cancer of the plasma cells): 47 people, 74.60%
  2. High Blood Pressure: 7 people, 11.11%
  3. Primary Myelofibrosis (primary disorder of the bone marrow): 5 people, 7.94%
  4. Gout (uric acid crystals building up in the body): 5 people, 7.94%
  5. Pain: 4 people, 6.35%

* Approximation only. Some reports may have incomplete information.

Do you take Proair hfa and Lenalidomide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Proair hfa and Lenalidomide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Proair hfa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Lenalidomide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Proair hfa and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lenalidomide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on albuterol sulfate and lenalidomide (the active ingredients of Proair hfa and Lenalidomide, respectively), and Proair hfa and Lenalidomide (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: